Heparin Sodium — Drug Intelligence | 9 EU Trials

Filter these 9 trials by condition, phase, country and more.

Open in Search →

9 Registered trials

4 Recruiting

3 Completed trials

8 Sponsors

6 Countries

Phase III

Phase II

Phase III/IV

Phase IV

Other

Phase III: 2 Phase II: 2 Phase III/IV: 1 Phase IV: 2 Other: 2

Indications tested

Atrial fibrillation 1 Peripheral arterial occlusive disease 1

Sponsors using this IMP

Medical University Of Vienna 2 Aplagon Oy 1 Assistance Publique Hopitaux De Paris 1 Centre Hospitalier Universitaire De Saint Etienne 1 Codadose Inc. 1 Karolinska University Hospital 1 Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy 1 Tarchominskie Zaklady Farmaceutyczne Polfa S.A. 1

All trials

9 total

HEMO trial - A randomized controlled trial of heparin bolus mobilization prior to peripheral hematopoietic cell collection from patients wit… Pending

2023-509534-18-01 Phase II 1 country Karolinska University Hospital
Strategy To Optimize PeriproCeduraL AnticOagulation in Structural Transseptal Interventions (STOP CLOT Trial) Pending

2024-516376-15-00 Phase III/IV 1 country Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut …
APAC (antiplatelet, anticoagulant) antithrombotic treatment for limb-threatening impairment of blood flow (HEALING-study) Recruiting

2025-522390-11-00 Phase II 1 country Aplagon Oy
LIPIOJOINT-2 : A randomized sham-controlled, double blind, multicenter trial on the effect of Genicular Arteries Embolization in symptomatic… Recruiting

2023-508844-24-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Comparing Anticoagulation Strategies using Unfractionated heparin, Argatroban and Low-molecular-weight heparin for Extracorporeal Membrane (… Recruiting

2024-518702-40-00 Phase IV 1 country Medical University Of Vienna
Best Antithrombotic Therapy in patients with acute Venous ThromboEmbolism while taking antiplatelets: the BAT-VTE Recruiting

2022-500974-33-00 Phase III 1 country Centre Hospitalier Universitaire De Saint Etienne
Randomized, Open-label, Single-Dose, Two-treatment, Two-period, Cross-over, Pivotal Bioequivalence Study Comparing Amoxicilin/Clavulanic aci… Ended

2023-503233-22-00 1 country Tarchominskie Zaklady Farmaceutyczne Polfa S.A.
Single Dose Crossover Comparative Bioavailability and Food Effect Study of Celecoxib 10 mg/1 mL Oral Suspension versus Celebrex®️ (celecoxib… Ended

2023-504052-99-00 1 country Codadose Inc.
An investigation of heart-lung support without blood thinners during lung transplantation. Ended

2024-519503-10-00 Phase IV 1 country Medical University Of Vienna

Showing 1–9 of 9 trials

← All drugs A–Z